1045 related articles for article (PubMed ID: 26830627)
1. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
2. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
[TBL] [Abstract][Full Text] [Related]
3. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK
Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanism of miltefosine-mediated death of Leishmania donovani.
Verma NK; Dey CS
Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114
[TBL] [Abstract][Full Text] [Related]
5. Oral combination of eugenol oleate and miltefosine induce immune response during experimental visceral leishmaniasis through nitric oxide generation with advanced cytokine demand.
Kar A; Charan Raja MR; Jayaraman A; Srinivasan S; Debnath J; Kar Mahapatra S
Cytokine; 2021 Oct; 146():155623. PubMed ID: 34144446
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin nanocapsules enhanced doxorubicin induced apoptosis against leishmaniasis via Th1 immune response.
Chaurasia M; Pawar VK; Jaiswal AK; Dube A; Paliwal SK; Chourasia MK
Int J Biol Macromol; 2015 Aug; 79():27-36. PubMed ID: 25931395
[TBL] [Abstract][Full Text] [Related]
10. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
Escobar P; Yardley V; Croft SL
Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A.
Zheng ZW; Li J; Chen H; He JL; Chen QW; Zhang JH; Zhou Q; Chen DL; Chen JP
Parasit Vectors; 2020 Feb; 13(1):94. PubMed ID: 32085719
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells.
Lee SJ; Kim MS; Park JY; Woo JS; Kim YK
Toxicology; 2008 Jun; 248(2-3):121-9. PubMed ID: 18450357
[TBL] [Abstract][Full Text] [Related]
13. Copper salisylaldoxime (CuSAL) imparts protective efficacy against visceral leishmaniasis by targeting Leishmania donovani topoisomerase IB.
Singh MK; Bhaumik SK; Karmakar S; Paul J; Sawoo S; Majumder HK; Roy A
Exp Parasitol; 2017 Apr; 175():8-20. PubMed ID: 28174102
[TBL] [Abstract][Full Text] [Related]
14. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
[TBL] [Abstract][Full Text] [Related]
15. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
16. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Croton caudatus Geisel leaf extract against experimental visceral leishmaniasis induces proinflammatory cytokines in vitro and in vivo.
Dey S; Mukherjee D; Chakraborty S; Mallick S; Dutta A; Ghosh J; Swapana N; Maiti S; Ghorai N; Singh CB; Pal C
Exp Parasitol; 2015; 151-152():84-95. PubMed ID: 25655407
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-Δ
Chen K; Li JJ; Li SN; Feng J; Liu T; Wang F; Dai WQ; Xia YJ; Lu J; Zhou YQ; Guo CY
Acta Pharmacol Sin; 2017 May; 38(5):672-687. PubMed ID: 28216619
[TBL] [Abstract][Full Text] [Related]
19. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B.
Shadab M; Jha B; Asad M; Deepthi M; Kamran M; Ali N
PLoS One; 2017; 12(2):e0171306. PubMed ID: 28170432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]